5/31/2016
`
`Jefferies Boosts PT on Antares Pharma (ATRS) 20% into OTREXUP PDUFA; Maintains Buy
`
`GET QUOTE
`
` Go SEARCH SITE
`
` Go
`
`Log-In | Home | E-mail Alerts | My Headlines | Portfolio
`
`Upgrade to StreetInsider Premium! - Free Trial
`
`Menu Calendars
`
`QUICK LINKS : Goldman Sachs Conviction Buy List Carl Icahn News Warren Buffett News Ackman News
`
`Follow @Street_Insider
`
`Analyst Comments, Analyst PT Change, FDA
`
`Jefferies Boosts PT on Antares Pharma (ATRS) 20% into OTREXUP PDUFA;
`Maintains Buy
`
`Article
`
`Related Articles (2)
`
`Stock Quotes (1)
`
`Comments (0)
`
`October 8, 2013 7:29 AM EDT
`Get Alerts
`ATRS Hot Sheet
`Price: $0.97 +5.43%
`
`Rating Summary:
` 5 Buy
`, 0 Hold
`
`, 0 Sell
`
`
`
`Rating Trend: = Flat
`
`
`
`Today's Overall Ratings:
` Up: 13 | Down: 19 | New: 12
`
`Trade ATRS Now!
`Join SI Premium – FREE
`
`Antare is looking for a mid-first-quarter 2014 launch with about 30
`reps targeting 2,500 to 3,000 U.S. rheumatologists. While some
`investors are negative about reimbursement for the drug, Livnat is positive given the following factors:
`
` Share
` Tweet
` E-mail
`Jefferies maintains a Buy rating and boosts its price target on
`Antares Pharma (Nasdaq: ATRS) from $5 up to $6 into OTREXUP
`PDUFA.
`
`Analyst Oren Livnat notes the the PDUFA date is scheduled for
`October 14th, but given that that is Columbus Day, action is
`expected on Friday October 11th. He comments, "OTREXUP
`should succeed with advantages vs. both oral/injectable MTX &
`receptive Managed Care looking to delay biologics. Current MTX
`market growth and pricing have been higher than we’d modeled,
`thus with still modest penetration assumptions, we raise
`OTREXUP ests. 20 percent to 25 percent."
`
`FREE Breaking News Alerts from StreetInsider.com!
`
`E-mail Address
`
` Subscribe
`
`StreetInsider.com Top Tickers, 5/31/2016
`
`1. CPXX
`2. JAZZ
`3. MKTO
`4. ICPT
`5. BABA
`
`6. AGN
`7. GXP
`8. WR
`9. VRX
`10. STEM
`
`Set up related e-mail alerts – FREE!
`1. will be 2nd line to oral MTX, yet 40 percent to 50 percent of RA patients ‘fail’ oral anyway,
`
`Top News
`
`Most Read
`
`Special Reports
`
`Close (X)
`
`2. is comparable (or cheaper?) than current injectable MTX if factoring in cost of physician admin.,
`and
`
`3. managed care would be thrilled for OTREXUP to just delay patient progression to biologics,
`saving well >$1,000/month.
`
`For an analyst ratings summary and ratings history on Antares click here. For more ratings news on
`Antares Pharma click here.
`
`Shares of Antares closed at $4.53 on Monday, with a 52 week range of $3.35 to $4.72.
`
`Serious News for Serious Traders! Try StreetInsider.com Premium Free!
`
`You May Also Be Interested In
`
`UPDATE: UBS Raises Price Target on Five Below (FIVE) to $47; Reiterates Buy
`Wedbush Cuts Price Target on Michael Kors (KORS) to $43 Following Checks and Peer
`reports
`Stifel Reiterates Buy on Prologis (PLD) After Hosting Client Meetings
`
`Wall St. ends May with whimper as energy
`shares slump
`SoftBank Plans Sale of Up to $7.9B of Alibaba
`(BABA) Shares as Part of Capital Raise
`Initiative
`Staples (SPLS) CEO Sargent to Step Down
`Under Armour (UA) Revises FY Outlook
`Following The Sports Authority Bankruptcy
`After-Hours Stock Movers 05/31: (ZOES) (BYD)
`(SRPT) Higher; (ADPT) (ASNA) (UA) (BABA)
`Lower (more...)
`
`Sponsored Videos
`Market Update
`
`http://www.streetinsider.com/Analyst+Comments/Jefferies+Boosts+PT+on+Antares+Pharma+%28ATRS%29+20%25+into+OTREXUP+PDUFA%3B+Mainta… 1/2
`
`Medac Exhibit 2077
`Frontier Therapeutics v. Medac
`IPR2016-00649
`Page 00001
`
`

`
`5/31/2016
`
`Jefferies Boosts PT on Antares Pharma (ATRS) 20% into OTREXUP PDUFA; Maintains Buy
`
`Market update for Friday May 20th
`
`Related Categories
`Analyst Comments, Analyst PT Change, FDA
`
`Create E-mail Alert
`
`Related Entities
`Jefferies & Co, Oren Livnat
`
`Add Your Comment
`
`Name
`
`Subject
`
`Body
`
`Login with Facebook
`
`Add Your Comment
`
`Sign up for StreetInsider Free!
`Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and
`more!
`
`E-mail Address
`
` Go!
`
`Home Member's Home Premium Content
`Links Entities About StreetInsider Get Our Content
`Advertise with Us Contact Us Disclaimer Privacy Policy
`
`
`
`Free News Feed
`Get our RSS Feed!
`
`© Copyright 2016 StreetInsider.com
`
`
`
`http://www.streetinsider.com/Analyst+Comments/Jefferies+Boosts+PT+on+Antares+Pharma+%28ATRS%29+20%25+into+OTREXUP+PDUFA%3B+Mainta… 2/2
`
`Page 00002